Stock listing
HKEX:2335 Shaanxi Micot Pharmaceutical Technology Co., Ltd. (麥科醫藥) 股價
Follow Shaanxi Micot Pharmaceutical Technology Co., Ltd. into a list and get an email when it puts out news.
Share price · HKEX:2335
$18.40 HKD -0.60 (-3.2%)
Close on Nov 20, 2026
- Day range
- $17.30 – $19.29 HKDNov 20, 2026
- Volume
- 3.02M sharesNov 20, 2026
- Market cap
- $6.10B HKDAt the close on Nov 20, 2026 · price × 331.7M shares outstanding
- Traded on an average day
- $58.26M HKDMedian day 606,700 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · HKEX:2335 · HKD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $18.40 | -0.60 | -3.2% | $18.88 | $19.29 | $17.30 | 3,021,800 | |
| $19.00 | -1.66 | -8.0% | $21.50 | $21.62 | $19.00 | 2,779,400 | |
| $20.66 | +0.86 | +4.3% | $19.26 | $21.30 | $19.26 | 2,812,400 | |
| $19.80 | -0.78 | -3.8% | $20.50 | $22.82 | $18.90 | 4,568,000 | |
| $20.58 | -1.10 | -5.1% | $21.70 | $25.30 | $19.41 | 10,628,600 | |
| $21.68 | +0.36 | +1.7% | $20.80 | $24.20 | $20.50 | 10,457,600 | |
| $21.32 | -1.80 | -7.8% | $23.32 | $23.78 | $21.18 | 3,982,000 | |
| $23.12 | -1.30 | -5.3% | $24.40 | $25.94 | $23.08 | 7,990,800 | |
| $24.42 | +5.61 | +29.8% | $18.59 | $24.48 | $18.34 | 12,704,200 | |
| $18.81 | +2.48 | +15.2% | $16.40 | $21.32 | $16.40 | 11,806,200 | |
| $16.33 | +0.41 | +2.6% | $16.17 | $16.99 | $15.40 | 4,003,800 | |
| $15.92 | -0.08 | -0.5% | $17.20 | $17.66 | $14.82 | 9,553,400 | |
| $16.00 | +3.99 | +33.2% | $12.05 | $20.24 | $12.02 | 26,883,000 | |
| $12.01 | +0.41 | +3.5% | $11.58 | $12.11 | $10.80 | 1,476,600 | |
| $11.60 | -2.01 | -14.8% | $14.20 | $14.20 | $11.41 | 2,597,000 | |
| $13.61 | -1.38 | -9.2% | $15.18 | $16.15 | $13.45 | 5,073,000 | |
| $14.99 | -0.09 | -0.6% | $15.36 | $16.12 | $14.62 | 3,643,200 | |
| $15.08 | +0.94 | +6.6% | $14.21 | $18.25 | $13.69 | 11,213,000 | |
| $14.14 | -0.28 | -1.9% | $14.65 | $15.45 | $13.79 | 2,311,400 | |
| $14.42 | -0.98 | -6.4% | $15.50 | $15.50 | $13.13 | 4,440,680 | |
| $15.40 | -0.92 | -5.6% | $16.50 | $20.60 | $14.68 | 14,020,400 | |
| $16.32 | -1.22 | -7.0% | $17.97 | $18.50 | $15.95 | 3,231,200 | |
| $17.54 | -6.46 | -26.9% | $23.00 | $24.60 | $17.36 | 6,029,800 | |
| $24.00 | +9.37 | +64.0% | $14.63 | $39.16 | $14.63 | 14,841,800 | |
| $14.63 | -1.62 | -10.0% | $16.25 | $16.79 | $14.00 | 387,800 | |
| $16.25 | -2.79 | -14.7% | $19.88 | $19.88 | $15.85 | 282,000 | |
| $19.04 | -2.86 | -13.1% | $21.50 | $21.68 | $15.02 | 535,400 | |
| $21.90 | -0.18 | -0.8% | $21.68 | $22.82 | $21.58 | 230,400 | |
| $22.08 | -0.56 | -2.5% | $22.58 | $22.78 | $21.90 | 327,800 | |
| $22.64 | +0.78 | +3.6% | $21.90 | $23.06 | $21.78 | 378,400 | |
| $21.86 | -0.84 | -3.7% | $22.74 | $22.76 | $21.40 | 168,800 | |
| $22.70 | +0.76 | +3.5% | $21.98 | $22.94 | $21.90 | 240,600 | |
| $21.94 | +0.16 | +0.7% | $21.82 | $22.28 | $21.72 | 161,200 | |
| $21.78 | +0.98 | +4.7% | $20.82 | $22.60 | $20.80 | 156,400 | |
| $20.80 | +0.14 | +0.7% | $20.50 | $21.14 | $20.50 | 270,600 | |
| $20.66 | +0.75 | +3.8% | $19.90 | $21.18 | $19.84 | 643,800 | |
| $19.91 | -1.23 | -5.8% | $21.10 | $21.20 | $19.87 | 371,800 | |
| $21.14 | -0.80 | -3.6% | $21.90 | $22.24 | $20.68 | 265,600 | |
| $21.94 | +0.06 | +0.3% | $21.86 | $22.30 | $21.38 | 516,800 | |
| $21.88 | -0.28 | -1.3% | $22.18 | $22.44 | $21.60 | 514,000 | |
| $22.16 | -0.30 | -1.3% | $22.50 | $22.74 | $22.12 | 569,400 | |
| $22.46 | +0.44 | +2.0% | $22.02 | $22.66 | $21.68 | 595,600 | |
| $22.02 | +0.42 | +1.9% | $21.62 | $22.32 | $21.60 | 850,200 | |
| $21.60 | +0.58 | +2.8% | $21.06 | $21.80 | $20.60 | 654,400 | |
| $21.02 | +0.06 | +0.3% | $21.00 | $21.74 | $20.84 | 437,800 | |
| $20.96 | +0.14 | +0.7% | $20.80 | $21.90 | $20.68 | 459,800 | |
| $20.82 | -1.16 | -5.3% | $21.94 | $22.60 | $20.66 | 634,600 | |
| $21.98 | -2.12 | -8.8% | $24.10 | $24.10 | $21.84 | 364,400 | |
| $24.10 | -1.94 | -7.5% | $26.06 | $26.50 | $23.84 | 725,600 | |
| $26.04 | -0.06 | -0.2% | $26.08 | $26.52 | $25.00 | 617,800 | |
| $26.10 | -0.22 | -0.8% | $26.08 | $27.10 | $25.28 | 770,400 | |
| $26.32 | -2.24 | -7.8% | $28.52 | $28.96 | $25.46 | 1,157,300 | |
| $28.56 | +0.02 | +0.1% | $28.58 | $28.96 | $27.98 | 395,600 | |
| $28.54 | +0.14 | +0.5% | $28.40 | $28.86 | $27.90 | 380,880 | |
| $28.40 | +0.20 | +0.7% | $28.22 | $28.72 | $28.10 | 291,600 | |
| $28.20 | -0.30 | -1.1% | $28.56 | $28.88 | $28.10 | 343,600 | |
| $28.50 | -0.30 | -1.0% | $28.78 | $28.78 | $26.80 | 322,600 | |
| $28.80 | -0.24 | -0.8% | $29.00 | $29.18 | $28.50 | 258,600 | |
| $29.04 | +0.38 | +1.3% | $28.64 | $29.16 | $28.60 | 339,200 | |
| $28.66 | +0.24 | +0.8% | $28.40 | $28.86 | $28.40 | 279,600 | |
| $28.42 | +0.10 | +0.4% | $28.30 | $28.76 | $28.06 | 265,600 | |
| $28.32 | -1.04 | -3.5% | $29.34 | $29.62 | $27.80 | 358,600 | |
| $29.36 | -0.84 | -2.8% | $30.18 | $30.38 | $29.04 | 306,400 | |
| $30.20 | -0.40 | -1.3% | $30.64 | $31.40 | $29.90 | 418,800 |
- Ticker
- HKEX:2335
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- HKEX
- Currency
- HKD
What changed lately
Latest news release · Nov 20, 2026
Poll results of the extraordinary general meeting held on 20 November 2026
Latest news
Voluntary announcement - all enrolled participants completed phase III clinical trial of MT1013
Nov 8, 2026
Closed $24.42 (+29.8%) on Nov 9, 2026
Announcement in relation to the postponement of the EGM and change of book closure period
Nov 6, 2026
Closed $24.42 (+29.8%) on Nov 9, 2026
Voluntary announcement - receipt of the first instalment of project funding under a national major science and technology project and obtaining ethics approval from the lead institution for the phase III clinical trial of MT200605
Nov 4, 2026
Closed $16.33 (+2.6%) on Nov 5, 2026
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2026
Nov 3, 2026
Closed $15.92 (-0.5%) on Nov 4, 2026
Proxy form for the extraordinary general meeting to be held on 10 November 2026
Oct 22, 2026
Closed $14.42 (-6.4%) on Oct 23, 2026
Notice of extraordinary general meeting
Oct 22, 2026
Closed $14.42 (-6.4%) on Oct 23, 2026
Proposed general mandate to repurchase h shares and notice of extraordinary general meeting
Oct 22, 2026
Closed $14.42 (-6.4%) on Oct 23, 2026
Proposed adoption of the h share incentive scheme and proposed general mandate to repurchase h shares
Oct 15, 2026
Closed $24.00 (+64.0%) on Oct 16, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Oct 6, 2026
Closed $21.86 (-3.7%) on Oct 7, 2026
Shaanxi Micot Pharmaceutical Technology Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 15 in the last 12 months · 15 in all · newest Nov 20, 2026 · oldest 2026
Valuation
Price/book 5.5× against a median of 3.4×: 6th lowest of 9 Biotechnology companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $4.70B HKD
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- Negative EBITDA
- Price/book
- 5.5×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H · HKEX:2335 | US$778.7M | US$600.0M | n/a | n/a | n/a | 5.5× | n/a | 0.0× | n/a |
| Odyssey Therapeutics, Inc. · NASDAQ:ODTX | US$815.2M | US$512.7M | n/a | n/a | n/a | 2.2× | n/a | 0.1× | 1.11 |
| NATURECELL Co., Ltd. · KRX:007390 | US$803.4M | US$787.5M | n/a | 51.4× | n/a | 17.1× | −13.2% | 0.0× | n/a |
| Arbutus Biopharma Corporation · NASDAQ:ABUS | US$796.4M | US$458.9M | 3.6× | 2.5× | 3.1× | 9.3× | 121.2% | 0.0× | 1.10 |
| Genfleet Therapeutics (Shanghai), Inc. Class H · HKEX:2595 | US$787.5M | US$519.4M | n/a | 26.6× | n/a | 3.3× | n/a | 0.0× | n/a |
| Ironwood Pharmaceuticals, Inc. · NASDAQ:IRWD | US$778.1M | US$702.9M | 5.2× | 1.8× | n/a | n/a | 37.4% | n/a | 1.16 |
| Syndax Pharmaceuticals, Inc. · NASDAQ:SNDX | US$772.7M | US$695.6M | n/a | 2.4× | n/a | n/a | −72.4% | n/a | 0.64 |
| MeiraGTx Holdings plc · NASDAQ:MGTX | US$766.4M | US$715.6M | 9.8× | 1.8× | 3.7× | 3.6× | 19.5% | 0.6× | 1.57 |
| ORIC Pharmaceuticals, Inc. · NASDAQ:ORIC | US$764.9M | US$503.6M | n/a | n/a | n/a | 2.3× | n/a | 0.0× | 1.22 |
| Inventiva SA · EURONEXT:IVA | US$760.9M | US$577.3M | n/a | 117× | n/a | 11.8× | n/a | 1.1× | n/a |
| Rigel Pharmaceuticals, Inc. · NASDAQ:RIGL | US$754.9M | US$663.4M | 2.5× | 2.3× | 8.3× | 1.7× | 106.6% | 0.0× | 1.02 |
| Median of the others | US$775.4M | US$620.4M | 4.4× | 2.5× | 3.7× | 3.4× | 28.4% | 0.0× | 1.11 |
Forecasts
Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.
- Price target
- 38.37 HKD · Analysts' mean
- EPS, year to Dec 2026
- -0.96 · 1 analyst
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Public offering of h Shares Update: HK$1.06B · HK$18.2 a share · 瑞邦證券 Dealers: 瑞邦證券 (co-lead) Buyers: Qiyuan Hong Kong (18,756,200 Offer Shares, 32.31% of Offer Shares, 5.65% of total issued share capital; cornerstone investor and close associate of existing Shareholders); Everest Medicine (5,494,400 H Shares as cornerstone investor); Summit Capital (430,400 H Shares as cornerstone investor) | Jun 23, 2026 | US$134.75M |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in CNY
Income statement
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | 0 | 0 |
| Research and development | 130.1M | 107.0M |
| Selling, general and administrative | 7.77M | 6.22M |
| Operating income | -153.3M | -125.1M |
| Depreciation and amortization | 6.57M | 8.39M |
| EBITDA | -146.7M | -116.7M |
| Interest expense | 67.0M | 37.6M |
| Income before tax | -184.9M | -156.8M |
| Net income | -182.5M | -154.6M |
| Earnings per share, basic | -0.55 | -0.47 |
Balance sheet
| Line | FY2025 | FY2024 |
|---|---|---|
| Cash and equivalents | 80.6M | 64.7M |
| Short-term investments | 155.5M | 115.2M |
| Current assets | 262.2M | 186.0M |
| Total assets | 331.5M | 247.3M |
| Accounts payable | 53.7M | 33.4M |
| Current liabilities | 266.4M | 77.9M |
| Long-term debt | 0 | 42.3M |
| Total liabilities | 1.29B | 120.5M |
| Shareholders' equity | -972.5M | 111.8M |
| Shares outstanding | 331.7M | 331.7M |
Cash flow
| Line | FY2025 | FY2024 |
|---|---|---|
| Cash from operations | -137.1M | -107.7M |
| Capital spending | -17.0M | -1.30M |
| Free cash flow | -154.1M | -109.0M |
| Change in cash | 17.5M | -31.8M |
Filings
All 15 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM | Sep 30, 2026 | Notification letter | HKEX |
| 2026 INTERIM REPORT | Sep 30, 2026 | Interim report | HKEX |
| ANNOUNCEMENT OF ALLOTMENT RESULTS | Jun 23, 2026 | Offer document | HKEX |
| LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | Jun 22, 2026 | List of directors | HKEX |
| Documents on Display | Jun 14, 2026 | Other filings | HKEX |
Cap table
Built by 6ix from Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H’s releases
- Common shares
- 331,740,400
- Fully diluted
- 331,740,400
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 331,740,400 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 331,740,400 |
Log in to ask 6ix AI your own questions about Shaanxi Micot Pharmaceutical Technology Co., Ltd.